Fan Mingdong, Zhou Zhongxing, Bruesewitz Michael, McCollough Cynthia, Yu Lifeng
Department of Radiology, Mayo Clinic, Rochester, MN, 55901, USA.
Proc SPIE Int Soc Opt Eng. 2023 Feb;12463. doi: 10.1117/12.2655619. Epub 2023 Apr 7.
The purpose of this work is to evaluate the low-contrast detectability on a clinical whole-body photon-counting-detector (PCD)-CT scanner and compare it with an energy-integrating-detector (EID) CT scanner, using an efficient Channelized Hotelling observer (CHO)-based method previously developed and optimized on the American College of Radiology (ACR) CT accreditation phantom for routine quality control (QC) purpose. The low-contrast module of an ACR CT phantom was scanned on both the PCD-CT and EID-CT scanners, each with 10 different positionings. For PCD-CT, data were acquired at 120 kV with two major scan modes, standard resolution (SR) (collimation: 144×0.4 mm) and ultra-high-resolution (UHR) (120×0.2 mm). Images were reconstructed with two major modes: virtual monochromatic energy at 70 keV and low-energy threshold (T3D), each with filtered-backprojection (Br44) and iterative reconstruction (Br44-3) kernels. For each positioning, 3 repeated scans were acquired for each scan mode at a fixed radiation dose setting (CTDIvol = 12 mGy). For EID-CT, scans (10 positionings × 3 repeated scans) were performed at a matched CTDIvol, and images were reconstructed using the same kernels with FBP and IR. A recently developed CHO-based method dedicated for QC of low-contrast performance on the ACR phantom was applied to calculate the low-contrast detectability (d') for each scan and reconstruction condition. Results showed that there was no significant difference in low-contrast detectability (d') between the UHR mode and SR mode (p = 0.360-0.942), and the T3D reconstruction resulted in 7.7%-14.6% higher d' than 70keV (p < 0.0016). Similar detectability levels were observed on PCD-CT and EID-CT. The PCD-CT: UHR-T3D had 6.2% higher d' than EID-CT with IR (p = 0.047) and 4.1% lower d' without IR (p = 0.122).
这项工作的目的是使用一种基于通道化霍特林观察者(CHO)的高效方法,评估临床全身光子计数探测器(PCD)CT扫描仪的低对比度可探测性,并将其与能量积分探测器(EID)CT扫描仪进行比较。该方法先前已针对美国放射学会(ACR)CT认证体模进行了开发和优化,用于常规质量控制(QC)目的。在PCD-CT和EID-CT扫描仪上对ACR CT体模的低对比度模块进行扫描,每种扫描仪均有10种不同的定位。对于PCD-CT,在120 kV下以两种主要扫描模式采集数据,即标准分辨率(SR)(准直:144×0.4 mm)和超高分辨率(UHR)(120×0.2 mm)。图像采用两种主要模式重建:70 keV的虚拟单色能量和低能量阈值(T3D),每种模式均使用滤波反投影(Br44)和迭代重建(Br44-3)内核。对于每种定位,在固定辐射剂量设置(CTDIvol = 12 mGy)下,每种扫描模式采集3次重复扫描。对于EID-CT,在匹配的CTDIvol下进行扫描(10种定位×3次重复扫描),并使用相同的内核通过FBP和IR重建图像。应用一种最近开发的基于CHO的方法来计算ACR体模上低对比度性能的质量控制,以计算每种扫描和重建条件下的低对比度可探测性(d')。结果表明,UHR模式和SR模式之间的低对比度可探测性(d')无显著差异(p = 0.360 - 0.942),并且T3D重建产生的d'比70keV高7.7% - 14.6%(p < 0.0016)。在PCD-CT和EID-CT上观察到相似的可探测性水平。PCD-CT的UHR-T3D的d'比具有IR的EID-CT高6.2%(p = 0.047),比没有IR的EID-CT低4.1%(p = 0.122)。